
Covid
COVID-19 positive patients at higher risk of developing neurodegenerative disorders, new study shows
COVID-19 positive outpatients are at an increased risk of neurodegenerative disorders compared with individuals who tested negative for the virus, a new study presented today at the 8th European Academy of Neurology (EAN) Congress has shown.
Immune boosting by B.1.1.529 (Omicron) depends on previous SARS-CoV-2 exposure
The Omicron, or Pango lineage B.1.1.529, variant of SARS-CoV-2 carries multiple spike mutations with high transmissibility and partial neutralizing antibody (nAb) escape. Vaccinated individuals show protection from severe disease, often attributed to ...
Viruses that were on hiatus during Covid are back — and behaving in unexpected ways
For nearly two years, as the Covid pandemic disrupted life around the globe, other infectious diseases were in retreat. Now the viral and bacterial nuisances are returning — and behaving in unexpected ways.
As reports of ‘Paxlovid rebound’ increase, Covid researchers scramble for answers
Early on, clinicians ruled out the most concerning possibility for Paxlovid rebound: that the virus was evolving resistance to the drug, a prospect that could undermine the treatment before it even had time to take off.
Monkeypox 101, unanswered questions, and the bigger picture
This month we’ve witnessed the global Avian flu outbreak, chocolates laced with salmonella, severe hepatitis of unknown cause among children, Ebola outbreak in West Africa, the first Polio case in Mozambique in 30 years, and . . . a global outbreak of monkeypox. I partnered with Dr.
Are we in a public health emergency?
We are clearly in the middle of an infection surge in the U.S. Hospitalizations are increasing but not reflecting case acceleration, and deaths are nearing pandemic lows. The individual risk of severe disease continues to decline thanks to immunity and treatments.